BindingDB logo
myBDB logout

16 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27460668 18 The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation.EBI Chinese Academy of Sciences
27096055 5 Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis.EBI Ajinomoto Co., Inc.
25461324 18 Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.EBI Chinese Academy of Sciences
23395658 49 Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands.EBI Okayama University 1-1-1
22483089 2 Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes.EBI Sichuan University
12036355 36 Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water.EBI University of Parma
21481589 14 New aromatic substituted pyrazoles as selective inhibitors of human adipocyte fatty acid-binding protein.EBI Chinese Academy of Sciences
20471252 22 Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening.EBI Chinese Academy of Sciences
19754198 5 Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins.EBI University of Minnesota
19217286 45 N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.EBI Biovitrum AB
17502136 66 Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP).EBI Bristol Myers-Squibb Pharmaceutical Research Institute
16884313 9 NMR structure of a potent small molecule inhibitor bound to human keratinocyte fatty acid-binding protein.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
15357970 26 Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitors.EBI Biovitrum AB
15357969 45 Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.EBI Biovitrum AB